Related Experiment Video
Updated: Dec 25, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
The Atrium and Embolic Stroke: Myopathy Not Atrial Fibrillation as the Requisite Determinant?
Jithin K Sajeev1, Jonathan M Kalman2, Helen Dewey3
1Monash University, Melbourne, Victoria, Australia; Department of Cardiology, Eastern Health, Melbourne, Victoria, Australia.
Insights
Atrial fibrillation (AF) may not be the sole cause of cardioembolic stroke. Adverse atrial remodeling, independent of rhythm, could be a key factor in clot formation and stroke risk.
Area of Science:
- Cardiology
- Neurology
- Biomedical Science
Background:
- Atrial fibrillation (AF) is linked to left atrial clot formation and cardioembolic stroke.
- Subclinical AF contributes significantly to embolic strokes of undetermined source.
- Recent trials showed limited benefit of anticoagulation for unselected stroke patients, prompting a search for better risk markers.
Purpose of the Study:
- To review evidence questioning AF as the sole prerequisite for left atrial thrombogenesis.
- To highlight adverse atrial remodeling, independent of AF rhythm, as a potential mechanism for stroke.
Main Methods:
- Literature review of randomized control trials and observational studies.
- Analysis of nonfibrillatory atrial electrical markers, structural, and biochemical abnormalities.
- Exploration of the relationship between vascular risk factors, atrial remodeling, and thrombogenesis.
Main Results:
- Inconsistencies exist in the evidence linking AF directly to left atrial thrombogenesis and stroke.
- Nonfibrillatory atrial electrical markers and structural abnormalities are associated with ischemic stroke, independent of AF.
- A complex interplay between vascular risk factors, atrial remodeling, and clot formation is evident.
Conclusions:
- Atrial myopathy markers may enable early identification of patients at risk for cardioembolic stroke.
- Adverse atrial remodeling, irrespective of AF presence, is a plausible mechanism for left atrial thrombogenesis and ischemic stroke.
Abstract:
Atrial fibrillation (AF) is well-recognized in the pathophysiology of left atrial thrombogenesis and resultant cardioembolic stroke. Subclinical AF is believed to account for a significant proportion of embolic stroke. However, recent randomized control trials failed to demonstrate a significant benefit for oral anticoagulation, in an unselected population with embolic stroke of undetermined source. This has reinvigorated the focus on finding robust markers to identify patients at risk of cardioembolic stroke. Several nonfibrillatory atrial electrical markers, along with structural and biochemical abnormalities, have been associated with ischemic stroke, independently of AF. An increasingly complex relationship exists among vascular risk factors, atrial remodeling, and thrombogenesis. Identifying robust markers of an underlying atrial myopathy may allow for early identification of patients at risk for cardioembolic stroke. This review outlines the inconsistencies in the evidence for AF as the prerequisite for left atrial thrombogenesis and embolic stroke. It will highlight the current evidence and controversies for adverse atrial remodeling, independent from rhythm, as a plausible mechanism for left atrial thrombogenesis and ischemic stroke.
Related Concept Videos
Myocarditis I: Introduction
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis II: Clinical Features and Diagnostic Tests
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Mechanism of Cardiac Arrhythmias

